article thumbnail

Episode 268: WDx #21 – Clinical Unknown with Dr. Rachael Lee

The Clinical Problem Solvers

[link] Maani and Emily are joined by Dr. Rachael Lee for a clinical unknown. She is the UAB Chief Healthcare Epidemiologist and in this role, she utilizes evidence based medicine to prevent the spread of healthcare-associated infections. Download CPSolvers App here RLRCPSOLVERS

Clinic 52
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interdisciplinary Case Report

CDOCS

We need to recognize how clinical dentistry has become intertwined with digital technologies to synergistically assist us in providing enhanced diagnosis with safe and predictable treatment outcomes. & I utilized 2CC of the mineralized freeze-dried allograft, particle size 500um to 1000um.

article thumbnail

A true story of payer negotiations

Physician's Practice

is a professor of clinical urology at Tulane University in New Orleans, Louisiana. Neil Baum, M.D. , Baum is the author of several books, including the best-selling book Marketing Your Medical Practice: Ethically, Effectively, Economically , which has sold over 225,000 copies and has been translated into Spanish.

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Dr. Jordan then questions the utility and continued operation of methadone clinics, especially as the United States largely moves on from the COVID-19 pandemic. Gillette moves the conversation into strategies addressing substance use disparities, particularly those that emphasize the importance of harm reduction.